Allogene Therapeutics Inc (ALLO) — Capital Reinvestment Ratio

Latest as of March 2018: 275.40x

Allogene Therapeutics Inc (ALLO) has a Capital Reinvestment Ratio of 275.40x as of March 2018, meaning it reinvests 275% of its operating cash flow ($5.00K) in capital expenditures ($1.38 Million). Check ALLO tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

275.40x

Capex / Operating Cash Flow

Operating Cash Flow

$5.00K

USD

Capital Expenditures

$1.38 Million

USD

Data as of

Mar 2018

Most recent filing

Annual Capital Reinvestment Ratio for Allogene Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Allogene Therapeutics Inc from None to None. See Allogene Therapeutics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow